Skip to content

The CHICA Developmental Screening Study

A Study to Determine if CHICA Can Improve Developmental Screening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01351077
Enrollment
360
Registered
2011-05-10
Start date
2011-05-31
Completion date
2012-12-31
Last updated
2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Delay

Keywords

Developmental Delay

Brief summary

The aims of this study are to (1) Expand and modify an existing computer-based decision support system (CHICA) to include the 2006 AAP developmental surveillance and screening algorithm; (2) Evaluate the effect of the CHICA system on the developmental surveillance and screening practices of four pediatric clinics; (3) Evaluate the effect of the CHICA system on referrals for developmental and medical evaluations as well as early developmental intervention/early childhood services for those children identified as having concerning developmental screening results; and (4) Develop a cohort of children with identified developmental disabilities that can be followed over time in order to look at the end results/effects of developmental screening

Detailed description

Between 12 and 16% of children in the United States have a developmental disability. Research has demonstrated that early intervention programs are not only essential for improved outcomes in these children, but also cost-effective. As a result, there has been a push within the pediatric medical community to identify children with developmental delays or disabilities as early as possible. Currently, most pediatric primary care providers do not use standardized methods for developmental surveillance and screening. Instead they rely on intuition and clinical judgment which has been shown to have limitations when compared with standardized screening methods. Researchers and physician organizations such as the AAP have called on pediatric primary care providers to institute a standardized approach for the identification of developmental delays that includes both developmental surveillance and screening. In fact, the AAP recently published an algorithm for developmental surveillance and screening within a primary care setting. Physicians, however, cite several barriers to the implementation of these recommendations within their practices, including lack of time, lack of office staff, inadequate reimbursement, and language barriers. The investigators have developed a novel computer decision support system (CDSS) for implementing clinical guidelines and algorithms within pediatric practices called CHICA. The investigators believe that this CDSS has the potential to address the barriers cited in previous studies as obstacles specific to the implementation of developmental surveillance and screening within primary care practices. CDSS will allow for developmental surveillance and screening to fit within the workflow of a busy pediatric practice without requiring an additional investment of time on the part of the physician and without requiring additional office staff. The aims of this study are to (1) Expand and modify an existing computer-based decision support system (CHICA) to include the 2006 AAP developmental surveillance and screening algorithm; (2) Evaluate the effect of the CHICA system on the developmental surveillance and screening practices of four pediatric clinics; (3) Evaluate the effect of the CHICA system on referrals for developmental and medical evaluations as well as early developmental intervention/early childhood services for those children identified as having concerning developmental screening results; and (4) Develop a cohort of children with identified developmental disabilities that can be followed over time in order to look at the end results/effects of developmental screening

Interventions

OTHERCHICA DevScreen Module

This module assists in the diagnosis and management of developmental screening

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Years
Healthy volunteers
Yes

Inclusion criteria

* This study will involve the analysis of data collected in the care of children seen in four IUMG-PC pediatric clinics. For aim 2 of the study all children between the ages of 0 and 3 seen in the four study clinics will be eligible for and will be participants in the study. For aim 3 of the study, a child is eligible for participation if they are younger than 5 years of age, have a concerning developmental screening result, and are seen in one of the four clinics participating in this study. Additionally, these children cannot have a previous diagnosis of a developmental disorder and at least one of the child's parents must speak English.

Exclusion criteria

* For aim 3, having no parents who can speak English

Design outcomes

Primary

MeasureTime frame
Number of Children Screened for Developmental Delayone year

Secondary

MeasureTime frame
Age of Children Diagnosed With Developmental Delayone year

Other

MeasureTime frame
Number of Children With a Positive Screenone year
Number of Children Referred for Evaluation and Services When There Was a Positive Screening Resultone year
Number of Patients Whose Referred Evaluations and Services Were Completedone year

Countries

United States

Participant flow

Participants by arm

ArmCount
CHICA DevScreen Module
This arm will get the CHICA Developmental Screening Module CHICA DevScreen Module: This module assists in the diagnosis and management of developmental screening
180
CHICA DevScreen Control
This arm will get CHICA without the developmental screening module
180
Total360

Baseline characteristics

CharacteristicCHICA DevScreen ControlTotalCHICA DevScreen Module
Age, Continuous23.7 months
STANDARD_DEVIATION 6.5
21.8 months
STANDARD_DEVIATION 5.8
19.8 months
STANDARD_DEVIATION 5.1
Insurance
Advantage/Commercial
6 Participants14 Participants8 Participants
Insurance
Medicaid
171 Participants331 Participants160 Participants
Insurance
Self-pay
2 Participants14 Participants12 Participants
Race/Ethnicity, Customized
Black
164 Participants215 Participants51 Participants
Race/Ethnicity, Customized
Hispanic
11 Participants128 Participants117 Participants
Race/Ethnicity, Customized
Other
1 Participants2 Participants1 Participants
Race/Ethnicity, Customized
White/Asian
4 Participants15 Participants11 Participants
Sex: Female, Male
Female
91 Participants188 Participants97 Participants
Sex: Female, Male
Male
89 Participants172 Participants83 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1800 / 180
serious
Total, serious adverse events
0 / 1800 / 180

Outcome results

Primary

Number of Children Screened for Developmental Delay

Time frame: one year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CHICA DevScreen ModuleNumber of Children Screened for Developmental Delay153 Participants
CHICA DevScreen ControlNumber of Children Screened for Developmental Delay44 Participants
Secondary

Age of Children Diagnosed With Developmental Delay

Time frame: one year

Population: The denominator was only children diagnosed with developmental delay

ArmMeasureValue (MEAN)Dispersion
CHICA DevScreen ModuleAge of Children Diagnosed With Developmental Delay19.8 monthsStandard Deviation 5.1
CHICA DevScreen ControlAge of Children Diagnosed With Developmental Delay23.8 monthsStandard Deviation 6.5
Other Pre-specified

Number of Children Referred for Evaluation and Services When There Was a Positive Screening Result

Time frame: one year

Population: The denominator was the number of children with a positive screen

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CHICA DevScreen ModuleNumber of Children Referred for Evaluation and Services When There Was a Positive Screening Result22 Participants
CHICA DevScreen ControlNumber of Children Referred for Evaluation and Services When There Was a Positive Screening Result4 Participants
Other Pre-specified

Number of Children With a Positive Screen

Time frame: one year

Population: The denominator was number of children for whom a standard developmental screening tool was administered

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CHICA DevScreen ModuleNumber of Children With a Positive Screen30 Participants
CHICA DevScreen ControlNumber of Children With a Positive Screen8 Participants
Other Pre-specified

Number of Patients Whose Referred Evaluations and Services Were Completed

Time frame: one year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CHICA DevScreen ModuleNumber of Patients Whose Referred Evaluations and Services Were Completed12 Participants
CHICA DevScreen ControlNumber of Patients Whose Referred Evaluations and Services Were Completed1 Participants

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026